Clinical and Genomic Characterization of Carbapenem-Resistant Klebsiella pneumoniae with Concurrent Production of NDM and OXA-48-like Carbapenemases in Southern California, 2016-2022

By sjmartinez • July 30, 2023

Cerón S, Salem-Bango Z, Contreras DA, Ranson EL, Yang S. Clinical and Genomic Characterization of Carbapenem-Resistant Klebsiella pneumoniae with Concurrent Production of NDM and OXA-48-like Carbapenemases in Southern California, 2016-2022. Microorganisms. 2023 Jun 30;11(7):1717. doi: 10.3390/microorganisms11071717. PMID: 37512889; PMCID: PMC10383945.

Tags: antimicrobial resistance, carbapenem-resistant Klebsiella pneumoniae, dual carbapenemase producer, Fellow, Infectious Diseases, NDM, OXA-181, OXA-232, Publications, Southern California, whole-genome sequencing

Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of Initial treatment for people living with HIV

Zheng Y, Currier JS, Hughes MD. Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of Initial[...]

Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in Serious Bacterial Infections

Goodman-Meza D, Weiss RE, Poimboeuf ML, Feng J, Vijayan T, Martinello M, Matthews GV, Dore GJ. Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in[...]

Preference for Service Delivery for Long-Acting Pre-exposure Prophylaxis for HIV Infection Among Pregnant and Breastfeeding Women in South Africa and Botswana

de Vos L, Mussa A, Rousseau E, Strauss M, George G, Vundhla P, Gebengu A, Tsuaneng M, Tamuthiba L, Tumagole A, Moshashane N, Morroni C,[...]